Skip to main content
Have a personal or library account? Click to login
Strategies to Manage Obesity: Endoscopic Bariatric and Metabolic Therapies Cover

Strategies to Manage Obesity: Endoscopic Bariatric and Metabolic Therapies

Open Access
|Feb 2025

References

  1. Seidell JC, Halberstadt J. The global burden of obesity and the challenges of prevention. Ann Nutr Metab. 2015;66 Suppl 2:7-12. doi: 10.1159/000375143
  2. CDC [Internet]. Atlanta, GA: Centers for Disease Control and Prevention; c2025. Emmerich SD, Fryar CD, Stierman B, Ogden CL. Obesity and Severe Obesity Prevalence in Adults: United States, August 2021-August 2023; 2024 Sep [cited 2025 Jan 21]. Available from: https://www.cdc.gov/nchs/products/databriefs/db508.htm
  3. Nguyen NT, Masoomi H, Magno CP, Nguyen XM, Laugenour K, Lane J. Trends in use of bariatric surgery, 2003-2008. J Am Coll Surg. Aug 2011;213(2):261-6. doi: 10.1016/j.jamcollsurg.2011.04.030
  4. Fayad L, Adam A, Schweitzer M, et al. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc. Apr 2019;89(4):782-788. doi: 10.1016/j.gie.2018.08.030
  5. McCarty TR, Thompson CC. The current state of bariatric endoscopy. Dig Endosc. Mar 2021;33(3):321-334. doi: 10.1111/den.13698
  6. McCarty TR, Thompson CC. Bariatric Endoscopy. In: Wang TC, Camilleri M, Lebwhohl, et al., editors. Yamada’ s Textbook of Gastroenterology, 7th Edition. Hoboken, NJ: Wiley-Blackwell; 2022. Chapter 108.
  7. McCarty TR, Kumar N. Revision Bariatric Procedures and Management of Complications from Bariatric Surgery. Dig Dis Sci. May 2022;67(5):1688-1701. doi: 10.1007/s10620-022-07397-9
  8. Therapy AATFoEB. A pathway to endoscopic bariatric therapies. Surg Obes Relat Dis. Nov-Dec 2011;7(6):672-82. doi: 10.1016/j.soard.2011.09.008
  9. Therapy AATFoEB, Ginsberg GG, Chand B, et al. A pathway to endoscopic bariatric therapies. Gastrointest Endosc. Nov 2011;74(5):943-53. doi: 10.1016/j.gie.2011.08.053
  10. ASGE Bariatric Endoscopy Task Force and ASGE Technology Committee; Abu Dayyeh BK, Kumar K, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015 Sep;82(3):425-38 e5. doi: 10.1016/j.gie.2015.03.1964
  11. ASMBS [Internet]. American Society for Metabolic and Bariatric Surgery, c2025. Bariatric Surgery Procedures; 2021 May [cited 2025 Jan 22]. Available from: https://asmbs.org/patients/bariatric-surgery-procedures
  12. Courcoulas A, Abu Dayyeh BK, Eaton L, et al. Intragastric balloon as an adjunct to lifestyle intervention: a randomized controlled trial. Int J Obes (Lond). Mar 2017;41(3):427-433. doi: 10.1038/ijo.2016.229
  13. Abu Dayyeh BK, Edmundowicz SA, Jonnalagadda S, et al. Endoscopic bariatric therapies. Gastrointest Endosc. 2015 May;81(5):1073-1086. doi: 10.1016/j.gie.2015.02.023
  14. Shah R, Davitkov P, Abu Dayyeh BK, Saumoy M, Murad MH. AGA Technical Review on Intragastric Balloons in the Management of Obesity. Gastroenterology. Apr 2021;160(5):1811-1830. doi: 10.1053/j.gastro.2021.02.043
  15. Shah RH, Vedantam S, Kumar S, Amin S, Pearlman M, Bhalla S. Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-Analysis. Obes Surg. Mar 2023;33(3):725-732. doi: 10.1007/s11695-022-06437-7
  16. Crea N, Pata G, Della Casa D, et al. Improvement of metabolic syndrome following intragastric balloon: 1 year follow-up analysis. Obes Surg. Aug 2009;19(8):1084-8. doi: 10.1007/s11695-009-9879-6
  17. Espinet-Coll E, Del Pozo-Garcia AJ, Turro-Arau R, et al. Evaluating the Safety of the Intragastric Balloon: Spanish Multicenter Experience in 20,680 Cases and with 12 Different Balloon Models. Obes Surg. 2024 Aug;34(8):2766-2777. doi: 10.1007/s11695-024-07342-x
  18. Fogel R, De Fogel J, Bonilla Y, De La Fuente R. Clinical experience of transoral suturing for an endoluminal vertical gastroplasty: 1-year follow-up in 64 patients. Gastrointest Endosc. 2008 Jul;68(1):51-58. doi: 10.1016/j.gie.2007.10.061
  19. Brethauer SA, Chand B, Schauer PR, Thompson CC. Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients. Surg Obes Relat Dis. 2010 Nov-Dec;6(6):689-94. doi: 10.1016/j.soard.2010.07.012
  20. Abu Dayyeh BK, Bazerbachi F, Vargas EJ, et al. Endoscopic sleeve gastroplasty for treatment of class 1 and 2 obesity (MERIT): a prospective, multicentre, randomised trial. Lancet. 2022 Aug 6;400(10350):441-451. doi: 10.1016/S0140-6736(22)01280-6
  21. Sharaiha RZ, Kumta NA, Saumoy M, et al. Endoscopic Sleeve Gastroplasty Significantly Reduces Body Mass Index and Metabolic Complications in Obese Patients. Clin Gastroenterol Hepatol. 2017 Apr;15(4):504-510. doi: 10.1016/j.cgh.2016.12.012
  22. Sharaiha RZ, Hajifathalian K, Kumar R, et al. Five-Year Outcomes of Endoscopic Sleeve Gastroplasty for the Treatment of Obesity. Clin Gastroenterol Hepatol. 2021 May;19(5):1051-1057 e2. doi: 10.1016/j.cgh.2020.09.055
  23. Alqahtani A, Al-Darwish A, Mahmoud AE, Alqahtani YA, Elahmedi M. Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc. 2019 Jun;89(6):1132-1138. doi: 10.1016/j.gie.2018.12.012
  24. Badurdeen D, Hoff AC, Hedjoudje A, et al. Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss. Gastrointest Endosc. 2021 Jun;93(6):1316-1324 e1. doi: 10.1016/j.gie.2020.10.016
  25. JC, Turro R, Mata A, et al. Early experience with the Incisionless Operating Platform (IOP) for the treatment of obesity : the Primary Obesity Surgery Endolumenal (POSE) procedure. Obes Surg. 2013 Sep;23(9):1375-83. doi: 10.1007/s11695-013-0937-8
  26. Sullivan S, Swain JM, Woodman G, et al. Randomized sham-controlled trial evaluating efficacy and safety of endoscopic gastric plication for primary obesity: The ESSENTIAL trial. Obesity. 2016 Dec;25(2):294-301. doi: 10.1002/oby.21702
  27. Miller K, Turro R, Greve JW, Bakker CM, Buchwald JN, Espinos JC. MILEPOST Multicenter Randomized Controlled Trial: 12-Month Weight Loss and Satiety Outcomes After pose (SM) vs. Medical Therapy. Obes Surg. 2017 Feb;27(2):310-322. doi: 10.1007/s11695-016-2295-9
  28. Espinos JC, Turro R, Moragas G, et al. Gastrointestinal physiological changes and their relationship to weight loss following the POSE procedure. Obes Surg. 2016 Sep;26(5):1081-1089. doi: 10.1007/s11695-015-1863-8
  29. Jirapinyo P, Thompson CC. Gastric plications for weight loss: distal primary obesity surgery endoluminal through a belt-and-suspenders approach. VideoGIE. 2018 Oct;3(10):296-300. doi: 10.1016/j.vgie.2018.08.002
  30. Huberty V, Boskoski I, Bove V, et al. Endoscopic sutured gastroplasty in addition to lifestyle modification: short-term efficacy in a controlled randomised trial. Gut. 2020 Oct;70(8). doi: 10.1136/gutjnl-2020-322026
  31. Matteo MV, Pontecorvi V, Bove V, et al. Prospective, single-arm multicenter, international, observational postmarket study to assess the safety and efficacy of a triangulation platform for treating patients requiring endoscopic gastroplasty. Gastrointest Endosc. 2025 Jan;101(1):106-116.e1. doi: 10.1016/j.gie.2024.06.041
  32. Alqahtani AR, Elahmedi M, Aldarwish A, Abdurabu HY, Alqahtani S. Endoscopic gastroplasty versus laparoscopic sleeve gastrectomy: a noninferiority propensity score-matched comparative study. Gastrointest Endosc. 2022 Jul;96(1):44-50. doi: 10.1016/j.gie.2022.02.050
  33. Thompson CC, Slattery J, Bundga ME, Lautz DB. Peroral endoscopic reduction of dilated gastrojejunal anastomosis after Roux-en-Y gastric bypass: a possible new option for patients with weight regain. Surg Endosc. 2006 Nov;20(11):1744-8. doi: 10.1007/s00464-006-0045-0
  34. Baretta GA, Alhinho HC, Matias JE, et al. Argon plasma coagulation of gastrojejunal anastomosis for weight regain after gastric bypass. Obes Surg. 2015 Jan;25(1):72-9. doi: 10.1007/s11695-014-1363-2
  35. Jirapinyo P, Chan WW, Thompson CC. Argon plasma coagulation is effective in Roux-En-Y gastric bypass patients that do not achieve weight loss goals after sutured transoral outlet reduction (TORe). Gastroenterology. 2017;152(5 Suppl 1):S635.
  36. Fittipaldi-Fernandez RJ, Zotarelli-Filho IJ, de Santana MF, et al. Roux-en-Y gastric bypass pouch outlet reduction using argon plasma coagulation to treat weight regain: a randomized controlled trial with a sham control group. Endosc Int Open. 2023 Apr;11(4):E426-E434. doi: 10.1055/a-2029-1845
  37. Moon RC, Teixeira AF, Neto MG, et al. Efficacy of Utilizing Argon Plasma Coagulation for Weight Regain in Roux-en-Y Gastric Bypass Patients: a Multi-center Study. Obes Surg. 2018 Sep;28(9):2737-2744. doi: 10.1007/s11695-018-3229-5
  38. Thompson CC, Chand B, Chen YK, et al. Endoscopic suturing for transoral outlet reduction increases weight loss after Roux-en-Y gastric bypass surgery. Gastroenterology. 2013 Jul;145(1):129-137.e3. doi: 10.1053/j.gastro.2013.04.002
  39. Jirapinyo P, Kroner PT, Thompson CC. Purse-string transoral outlet reduction (TORe) is effective at inducing weight loss and improvement in metabolic comorbidities after Roux-en-Y gastric bypass. Endoscopy. 2018 Apr;50(4):371-377. doi: 10.1055/s-0043-122380
  40. Kumar N, Thompson CC. Transoral outlet reduction for weight regain after gastric bypass: long-term follow-up. Gastrointest Endosc. 2016 Apr;83(4):776-9. doi: 10.1016/j.gie.2015.08.039
  41. Espinet Coll E, Nebreda Duran J, Lopez-Nava Breviere G, et al. Efficacy and safety of transoral outlet reduction via endoscopic suturing in patients with weight regain after a surgical Roux-en-Y gastric bypass. Rev Esp Enferm Dig. 2018 Sep;110(9):551-556. doi: 10.17235/reed.2018.5419/2017
  42. Jirapinyo P, Kumar N, AlSamman MA, Thompson CC. Five-year outcomes of transoral outlet reduction for the treatment of weight regain after Roux-en-Y gastric bypass. Gastrointest Endosc. 2020 May;91(5):1067-1073. doi: 10.1016/j.gie.2019.11.044
  43. Kumbhari V, Cai JX, Tieu AH, Kalloo AN, Khashab MA. Over-the-scope clips for transoral gastric outlet reduction as salvage therapy for weight regain after Roux-en-Y gastric bypass. Endoscopy. 2015;47 Suppl 1 UCTN:E253-4. doi: 10.1055/s-0034-1391951
  44. Vargas EJ, Bazerbachi F, Rizk M, et al. Transoral outlet reduction with full thickness endoscopic suturing for weight regain after gastric bypass: a large multicenter international experience and meta-analysis. Surg Endosc. 2018 Jan;32(1):252-259. doi: 10.1007/s00464-017-5671-1
  45. Jaruvongvanich V, Vantanasiri K, Laoveeravat P, et al. Endoscopic full-thickness suturing plus argon plasma mucosal coagulation versus argon plasma mucosal coagulation alone for weight regain after gastric bypass: a systematic review and meta-analysis. Gastrointest Endosc. 2020 Dec;92(6):1164-1175 e6. doi: 10.1016/j.gie.2020.07.013
  46. Dolan RD, Jirapinyo P, Thompson CC. Endoscopic versus surgical gastrojejunal revision for weight regain in Roux-en-Y gastric bypass patients: 5-year safety and efficacy comparison. Gastrointest Endosc. 2021 Nov;94(5):945-950. doi: 10.1016/j.gie.2021.06.009
  47. Dolan RD, McCarty TR, Jirapinyo P, Thompson CC. Endoscopic revision of gastric bypass using plication technique: an adjustable approach. VideoGIE. 2021 Jul;6(7):311-315. doi: 10.1016/j.vgie.2021.04.001
  48. Mullady DK, Lautz DB, Thompson CC. Treatment of weight regain after gastric bypass surgery when using a new endoscopic platform: initial experience and early outcomes (with video). Gastrointest Endosc. 2009 Sep;70(3):440-4. doi: 10.1016/j.gie.2009.01.042
  49. Horgan S, Jacobsen G, Weiss GD, et al. Incisionless revision of post-Roux-en-Y bypass stomal and pouch dilation: multicenter registry results. Surg Obes Relat Dis. 2010 May-Jun;6(3):290-5. doi: 10.1016/j.soard.2009.12.011
  50. Ryou M, Mullady DK, Lautz DB, Thompson CC. Pilot study evaluating technical feasibility and early outcomes of second-generation endosurgical platform for treatment of weight regain after gastric bypass surgery. Surg Obes Relat Dis. 2009 Jul-Aug;5(4):450-4. doi: 10.1016/j.soard.2009.03.217
  51. Zobel M, Yoo J, Posselt A, et al. Endoscopic Gastric and Gastrojejunostomy Plication for Revision of Gastric Bypass. Surg Obes Relat Dis. 2019 Oct;15(10), S111. doi: 10.1016/j.soard.2019.08.228
  52. Jirapinyo P, de Moura DTH, Thompson CC. Sleeve in sleeve: endoscopic revision for weight regain after sleeve gastrectomy. VideoGIE. 2019 Oct;4(10):454-457. doi: 10.1016/j.vgie.2019.07.003
  53. Bazarbashi AN, Jirapinyo P, Thompson CC. Endoscopic Sleeve-in-Sleeve Versus Surgical Re-Sleeve in Patients with Weight Regain After Sleeve Gastrectomy: A Retrospective Comparative Analysis. Gastrointest Endosc 2020;91(6);Supp:AB226.
  54. McCarty TR, Thompson CC. Bariatric and Metabolic Therapies Targeting the Small Intestine. Tech Innov Gastrointest Endosc. 2020 Jul;22(3):145-153. doi: 10.1016/j.tige.2020.03.008
  55. Rajagopalan H, Cherrington AD, Thompson CC, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study. Diabetes Care. 2016 Dec;39(12):2254-2261. doi: 10.2337/dc16-0383
  56. van Baar AC, Holleman F, Crenier L, et al. Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study. Gut. 2020 Feb;69(2):295-303. doi: 10.1136/gutjnl-2019-318349
  57. Busch CBE, Meiring S, van Baar ACG, Holleman F, Nieuwdorp M, Bergman J. Recellularization via electroporation therapy of the duodenum combined with glucagon-like peptide 1 receptor agonist to replace insulin therapy in patients with type 2 diabetes: 12-month results of a first-in-human study. Gastrointest Endosc. 2024 Nov;100(5):896-904. doi: 10.1016/j.gie.2024.04.2904
  58. Rodriguez L, Reyes E, Fagalde P, et al. Pilot clinical study of an endoscopic, removable duodenal-jejunal bypass liner for the treatment of type 2 diabetes. Diabetes Technol Ther. 2009 Nov;11(11):725-32. doi: 10.1089/dia.2009.0063
  59. Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010 May;71(6):976-82. doi: 10.1016/j.gie.2009.11.051
  60. Koehestanie P, de Jonge C, Berends FJ, Janssen IM, Bouvy ND, Greve JWM. The effect of the endoscopic duodenal-jejunal bypass liner on obesity and type 2 diabetes mellitus, a multicenter randomized controlled trial. Ann Surg. 2014 Dec;260(6):984-92. doi: 10.1097/SLA.0000000000000794
DOI: https://doi.org/10.14797/mdcvj.1518 | Journal eISSN: 1947-6108
Language: English
Page range: 74 - 83
Submitted on: Nov 4, 2024
Accepted on: Jan 21, 2025
Published on: Feb 18, 2025
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2025 Ronan P. Allencherril, Thomas R. McCarty, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.